{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:42:22Z","timestamp":1794624142845,"version":"4.9.1"},"reference-count":66,"publisher":"Informa UK Limited","issue":"6","funder":[{"name":"No funding"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2024,6,2]]},"DOI":"10.1080\/1744666x.2024.2306225","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T14:52:41Z","timestamp":1705157561000},"page":"577-587","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["A critical evaluation of nemolizumab for prurigo nodularis"],"prefix":"10.1080","volume":"20","author":[{"given":"Sarah G.","family":"Brooks","sequence":"first","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miami Itch Center, University of Miami Miller School of Medicine, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Yosipovitch","sequence":"additional","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miami Itch Center, University of Miami Miller School of Medicine, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1916733"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14570"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.06.045"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2020.10.009"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.07.697"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21843"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.183"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.04.047"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10306.x"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70006-2"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.02.061"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16834"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.182"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1852080"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14320"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.873"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3086"},{"key":"e_1_3_5_20_1","first-page":"82","volume-title":"Clinical immunology e-book: principles and practice","author":"Rich RR","year":"2012","unstructured":"Rich RR, Fleisher TA, Shearer WT, et al. Clinical immunology e-book: principles and practice. 6th ed. Vol. 145. Elsevier Health Sciences; 2012. p. 82\u201388.","edition":"6"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10498.x"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14709"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-017-0177-y"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.09.020"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.07.025"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2018.02.003"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.07.022"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S316602"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02320-9"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2023.2268291"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1853024"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1092685"},{"key":"e_1_3_5_34_1","volume-title":"Presented at: European Academy of Dermatology and Venereology Congress 2023","author":"Kwatra S","year":"2023","unstructured":"Kwatra S, Bordeaux Z, Pritchard T, et al. Efficacy, safety, and mechanism of action of abrocitinib in the treatment of prurigo nodularis and chronic pruritus of unknown origin. Presented at: European Academy of Dermatology and Venereology Congress 2023; Oct 11-14, 2023; Berlin, Germany."},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2022.0065"},{"key":"e_1_3_5_36_1","unstructured":"A study to evaluate the efficacy and safety of INCB054707 in participants with prurigo nodularis NCT05061693. ClinicalTrials.Gov 2023. [cited 22 Dec 2023]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05061693"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_362_2023"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.idoj_508_22"},{"key":"e_1_3_5_39_1","first-page":"1","volume-title":"Cytokines and cytokine receptors in clinical immunology, principles and practice","author":"Shea J","year":"2001","unstructured":"Shea J, Frucht D, Duchett C. Cytokines and cytokine receptors in clinical immunology, principles and practice. 2nd ed. Basel, Switzerland: Karger AG; 2001. p. 1\u201322. Mosby Ch12 (1)","edition":"2"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12206690"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1159\/000523700"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.04.085"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101826"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14279"},{"key":"e_1_3_5_46_1","unstructured":"Study to assess the efficacy safety and tolerability of Vixarelimab in reducing Pruritus in Prurigo Nodularis. ClinicalTrials.Gov #NCT03816891. Last Updated August 16 2023."},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2023.06.005"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01741-z"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908316"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2021.12.014"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.10.045"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxq027"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1159\/000211376"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12875"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2022.06.001"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.10.004"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00678-7"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.969"},{"key":"e_1_3_5_59_1","unstructured":"Mullins TB Sharma P Riley CA et al. Prurigo Nodularis. [Updated 2022 Sep 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459204\/"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21032"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3655"},{"key":"e_1_3_5_63_1","unstructured":"An efficacy and safety study of Nemolizumab (CD14152) in participants with Prurigo Nodularis. ClinicalTrials.Gove #NCT04501666. Updated June 28 2023."},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2301333"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18377"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.03.018"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917006"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.08.013"},{"key":"e_1_3_5_72_1","volume-title":"Late-breaking abstract presented at EADV 2023","author":"Stander S","unstructured":"Stander S. Nemolizumab monotherapy improves itch and skin lesions in patients with moderate-to-severe prurigo nodularis: results from a global phase 3 trial (OLYMPIA 1). Late-breaking abstract presented at EADV 2023; Berlin, Germany."},{"key":"e_1_3_5_73_1","unstructured":"A long-term study of nemolizumab (CD14152) in participants with prurigo nodularis (PN). Clinicaltrials.Gov #NTC04204616. [updated Apr 24 2023; cited 2023 Sep 15]."},{"key":"e_1_3_5_74_1","unstructured":"Galderma announces topline results of OLYMPIA 2 study evaluating Nemolizumab in Prurigo Nodularis (Press Release on Jun 22 2022) https:\/\/www.chugai-pharm.co.jp\/english\/news\/detail\/20220622160000_930.html"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2024.2306225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T14:46:48Z","timestamp":1727189208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2024.2306225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,2]]}},"alternative-id":["10.1080\/1744666X.2024.2306225"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2024.2306225","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}